Lorillard
II. C Tracer Studies to Develop Sampling Protocols for Quantitative Nicotine Dosimetry Following Smoke Exposure
Fields
- Author
- Caton, J.E.
- Harvey, R.W.
- Henderson, G.M.
- Jenkins, R.A.
- Maskarinec, M.P.
- Type
- SCRT, SCIENTIFIC REPORT
- CHAR, CHART/GRAPH/MAPS
- Alias
- 89737870/89737876
- Area
- SPEARS,ALEXANDER/EXEC CONF ROOM STO
- Site
- G65
- Master ID
- 89737566/7894
- 89737566-7894 Annual Report Collection, Separation, and Elucidation of the Components of Cigarette Smoke and Cigarette Smoke Condensate Part I. Chemical Characterization of Experimental Cigarette Smokes Part II. Inhalation Bioassay Monitoring and Support Part III. Dosimetry and Bioimpact
- 89737577-7588 I. Chemical Characterization of Tobacco Smoke From Beagle Dog Inhalation Exposure Systems
- 89737589 II. Final Data - Series IV Cigarette Smoke and Condensate Chemical Analyses
- 89737590-7599 Topical Report NCI / S&Hp / Ornl Number 52 Final Smoke and Condensate Data for the Fourth Series of Experimental Varia Nts
- 89737600-7602 III. Chemical Analysis of Smokes of Foreign and Domestic Commercial Cigarettes
- 89737603-7606 Topical Report NCI / S&Hp / Ornl Number 49 Tar, Nicotine, Co and Co2 Deliveries of Philippine Cigarettes
- 89737607-7610 Topical Report NCI / S&Hp / Ornl Number 61 Tar, Nicotine, Co and Co2 Deliveries of Philippine Cigarettes
- 89737611-7614 Topical Report NCI / S&Hp / Ornl Number 66 Tar, Nicotine, Co and Co2 Deliveries of Italian Cigarettes
- 89737615-7621 Topical Report NCI / S&Hp / Ornl Number 51-A Chemical Analysis of Smoke From Second Set of Certain Domestic Commercial Low Tar and Nicotine Cigarettes
- 89737622-7624 Topical Report NCI / S&Hp / Ornl Number 53 Chemical Analysis of Smoke From Second Set of Certain Domestic Commercial Low Tar and Nicotine Cigarettes
- 89737625-7632 Topical Report NCI / S&Hp / Ornl Number 68 Chemical Analysis of Smoke From Selected South Florida Variants
- 89737633-7647 Topical Report NCI / S&Hp / Ornl Number 70 Chemical Analyses of Smoke From Selected Foreign Cigarettes United Kingdom, Uk Export, and Developing Nations
- 89737648-7649 IV. Swri Baboon Study Smoking Extremes Experiment
- 89737650-7655 Topical Report NCI / S&Hp / Ornl Number 58 Chemical Analysis of Smoke Delivered by Swri Baboon Study Cigarette Under Three Smoking Conditions
- 89737656-7661 V. Statistical Modeling of Histopathological Probabilities
- 89737669-7682 I. Monitoring of the Chronic Inhalation Exposures
- 89737683-7698 Topical Report NCI / S&Hp / Ornl Number 41 Site Visit I to Battelle Pacific Northwest Laboratories Rat Model Inhalatio N Bioassay Richland, Washington, 770223 - 770224
- 89737699-7714 Topical Report NCI / S&Hp / Ornl Number 44 Site Visit Vi to Veteran's Administration Hospital East Orange, New Jersey, 770502 - 770503
- 89737715-7729 Topical Report NCI / S&Hp / Ornl Number 46 Site Visit IV to Hazleton Laboratory Reston, Virginia, 770521 - 770522
- 89737730-7748 Topical Report NCI / S&Hp / Ornl Number 48 Site Visit I to Enviro Control Inc. Inhalation Laboratories Temple Hills, M Aryland, 770523 - 770525
- 89737749-7760 Topical Report NCI / S&Hp / Ornl Number 54 Site Visit Vii to Veteran's Administration Hospital East Orange, New Jersey, 770808 - 770809
- 89737761-7768 Topical Report NCI / S&Hp / Ornl Number 55 Intercomparison of Tobacco Smoke Dose Beagle Dog Inhalation Bioassays
- 89737769-7777 Topical Report NCI / S&Hp / Ornl Number 59 Inhalation Bioassay of Tobacco Smoke in Pigeons Site Visit I to Beth Israel Hospital (Bih) Boston Massachusetts, 771130 - 771201
- 89737778-7798 Topical Report NCI / S&Hp / Ornl Number 60 Site Visit II to Battelle Pacific Northwest Laboratories Rat Model Inhalati on Bioassay Richland, Washington, 770914 - 770915
- 89737799-7817 Topical Report NCI / S&Hp / Ornl Number 62 Site Visit II to Borriston Research Laboratories Temple Hills, Maryland, 77 1107 - 771109
- 89737818-7833 Topical Report NCI / S&Hp / Ornl Number 64 Site Visit V to Hazleton Laboratories Reston, Virginia, 771105 - 771106
- 89737834-7844 Topical Report NCI / S&Hp / Ornl Number 67 Site Visit I to the Hazleton Laboratories Cofactor Inhalation Bioassay Rest on, Virginia, 780223
- 89737845-7856 II. Instrumental Approaches to Bioassay Monitoring
- 89737857-7858 III. Trapping and Determination of Organic Gas Phase Constituents of Cigarette Smoke
- 89737859-7862 Trapping and Determination of Labile Compounds in the Gas Phase of Cigarette Smoke
- 89737863-7865 IV. Determination of Nitric Oxide and Nitrogen Dioxide in Cigarette Smoke by Chemiluminescent Analysis
- 89737868-7869 I. Brl - Ornl Collaborative Smoke Particulate Deposition Experiment
- 89737877-7884 III. Isolation and Quantitative Analysis of Nicotine and Cotinine in Physiological Fluids
- 89737885-7894 IV. Physiological Fluids Studies: Mutagenicity and Profiling
Related Documents:
Document Images
315
II. I4C TRACER STUDIES TO DEVELOP SAMPLING
PROTOCCILS FOR QUANTITATIVE NICOTINE DOSIMETRY
FOLLOWING SMOKE EXPOSURE
J. E. Caton, R. A. Jenkins, M. P. Maskarinec
G. M. Henderson, and R. W. Harvey
The ability to determine cigarette smoke dose by performing a simple
analysis on a sample obtained non-destructively from the smoking subject
has long been a goal of smoking and health studies. The estimation of the
levels of nicotine and0or its metabolites has always been considered a
possible approach to the estimation of smoke uptake because (1) the only
source of nicotine is tobacco; (2) nicotine is a major component of both
the tobacco and the smoke aerosol and (3) nicotine is readily absorbed into
the biological system. Because of these properties (angular origin, abun-
dance, and efficiency of adsorption), the level of nicotine and its meta-
bolites in the serum or urine of a smoking subject would appear to be an
excellent indication of the dose of cigarette smoke retained. However,
there is some question concerning the reliability of nicotine measurements
as a quantitative indicator of smoke uptake because nicotine is rapidly
metabolized and distributed throughout the biological system. In order to
address these concerns, a collaborative effort between Borriston Research
Laboratories at ORNL was established to determine the utility of analyzing
either the serum or urine from a smoking dog for nicotine and/or its meta-
bolites in order to estimate cigarette smoke uptake by the animal.
The experimental approach to this study was to expose a dog to two
successive Code 32 (SEB IV) cigarettes labeled with 14C-nicotine bitartrate
and continuously monitor the blood and urine both during and for some period~
of time after the smoke exposure. Continuous withdrawal of blood was accomp-
lished by connecting a peristaltic pump to a cannula in the jugular vein and
pumping at 0.5 ml/min. In practice flexible cannulae were inserted into

316
both jugular veins and sutured in place. This presented a second source
of blood in the event of a blockage by clotting or irreversible bending of the
flexible cannula. After the first preliminary study on August 11, 1977, all
dogs were given heparin I.V. prior to exposure in order to minimize blockage
caused by clotting. Urine was collected by bladder catheterization. Three
preliminary studies were carried out on single dogs on August 11, 1977,
October 10, 1977, and December 15, 1977. Based on these preliminary studies
the following general procedure was established: Blood was collected at the
rate of 0.5 ml/min starting at least 2 min. before smoke exposure and continu-
ing for 45 min after the termination of smoke exposure. The blood was frac-
tionated at 2-min intervals. Urine collection was also started before smoke
exposure with the blank sample being the urine collected during catheteriza-
tion. The collection interval for each sample was 15 min for the first 6 hr.
The dog was then placed in a metabolic cage and the urine was collected on a
24-hr basis for 4 days.
Five dogs were exposed according to the above procedure on March 20-22,
1978. After exposure, one of these dogs refused to cooperate and no signifi-
cant samples were obtained. Excellent sets of samples were obtained from the
remaining four dogs; the results are presented in Tables III-1 and 111-2. The
14C-activity measured in the blood increased quite rapidly after the i,nitia-
tion of exposure to the labeled cigarette. The level of activity in the blood
reached a maximum at the end of the exposure to the second cigarette. After
smoke exposure is completed there is a sharp decline in the activity detected
in the blood (Figure III-1). This sharp decline slows significantly at 10
to 12 minutes after smoke exposure as indicated in Figure III-1.
The 14C-activity in the urine is summarized in Table 111-2. Significant
amounts of 14C-activity begin to appear in the urine about 1 hr after the
beginning of exposure to smoke. Elimination is very rapid during the next
3 hr. However, significant amounts are eliminated over a 3-day period as
indicated in Figure 111-2.

317
TABLE III-1
Concentration of Nicotine in Dog Mood as Function of Time After Start
of Smoke Exposure to Smoke Containing 14C-Nicotine Bitartrate
Nicotine Concentration, ng/m1a
Dog g No.
Timeb, rs~n n.
5249
5244
5172
5272
0 0 0 0 0
2 8 16 13 24
4 64 54 38 34
6 132 73 46 41
8 123 60 83 40
10 114 55 97 59
12 124 62 112
14 120 87 138
16 129 83 109
18 127 78 98
20 102 102 57 97
22 102 90 86
24 79 90 78
26 64 85 77
28 62 72 56 70
30 57 74 37 69
32 53 69 41 65
34 48 69 33 61
36 44 71 33 57
38 40 71 38 59
40 41 63 32 57
42 41 54 30 57
44 39 60 32 53
46 36 54 28 55
48 40 60 28 60
50 35 53 28 48
52 35 54 21 47
54 34 54 48
56 31 50 45
58 32 52 42
60 37 44 33
aNicotine concentration is that amount of nicotine that
should be present if all the material being traced by
the 14C-activity were still present as nicotine. This
is certainly not the case. Thus, the numbers in this
Table represent concentrations of nicotine plus its
metabolites expressed in terms of nicotine.
bTime that the exposure to the second labeled cigarette
ended.

318
TABLE 111-2
Total Amount of Nicot4ne Eliminated in Urine
as a Function of Time After Start of Exposure to Smoke
from Cigarettes Labeled with i4C-nicotine Bitartrate
Plicotine Eliminated in Urine, ug a
Dog No.
Timeb, h.5249 5244 5172 5272
0 0 0 0 0
0.25 0.7 0.1 0
0.5 2 2 0.1 7.6
0.75 28 2 0.3 113
1.0 120 22 0.4 206
1.5 278 377 298 425
2.0 435 641 426 477
2.5 604 772 488 596
3.0 737 929 726 862
3.5 814 1072 819 1051
4.0 888 1171 895 1148
4.5 1018 1275 952 1369
5.0 1060 1317 991 1376
5.5 1386 1027 1462
6.0 1489 1133 1625
20 1341 1796 1260 2048
30 1821 1315 2176
40 1444 1848 1357 2229
50 1928 2240
70 1473 1950 2243
80 1523 1370
90 1532
aNicotine eliminated is actually the amount of 14C-tracer
eliminated expressed in terms of the nicotine originally
in the cigarette. Much of this tracer is now present as
some metabol i te of ni coti ne.
bFor comparison purposes sampling times have been
rounded-off.

FIGURE III-1
NIC®TINEaIN BLOOD
e: Dog 5172
CI: Dog 5249
t: Dog 5272
91 `j~ (I GL o: Dog 5244
~
~ N
-1.00
12.33 25.67 39.00 52.33 65.67
TIME ELAPSEQ SINCE START OF SMQKING'
79.00
(minutes)
a{Vicotine concentration is amount indicated by i`~C activity and actually ~
represents sum of nicotine plus metabolites. ,~
bEnd of exposure to the second of two labelled cigarettes is taken as ~
zero timeU

32©
FIGURE 111-2
NICOTINEaIN URINE
0
C'7
®
~ N ~
CM 0
0
0! B
U ~
~co 1
®
LQ 0
C~1 e
~
E-
~
zQ
~ 6
L4
~
~
LO ~ ®
~ L
~
z ~
~
° ®~
~
z lb A: Dog 5172
0
® Q: Dog 5249
~ +: Dog 5272
Oc
° o: Dog 5244
~
E-1 v+ ®
9
Q
Q ~
0
0.00
16.67 33.33 50.00 66.67 83.33 100.00
TIME ELAPSED SINCE START OF SMOKING
(Hours)
a7otal nicotine is amount indicated by 1'*C activity and actually represents
sum of nicotine plus metabolites.

321
Final evaluation of the results have not been completed. Preliminary
indications from the blood tracer 1evels suggest that the nicotine/cotinine
levels in serum may be too transient to obtain meaningful samples. 14C-
levels in urine indicate that a very large fraction of the total nicotine
dose is excreted in the first few hours following smoke exposure. In a
chronic exposure situation, animals are often exposed over a 10-12 hour
span each day. The data suggest that to obtain a meaningful sample, all
urine voided during the day, including that eliminated during smoke exposure,
should be collected. Also, from Figure 111-2, the elimination of the 14C
label undergoes a sharp change in slope when the animal is placed in the
metabolic cage. This is somewhat unexpected, since a smoother approach
to a steady state condition would be the more usual case. This suggests
that another mechanism is controlling the apparent excretion of the 14C
label. It is entirely possible that when the animal excretes the urine
on the surfaces of the metabolic cage, a significant fraction of the nico-
tine (or its metabolites) is lost, either due to volatility across the
large surface area or a reaction with either the stainless steel surface
or a contaminant on that surface. Further experiments will be necessary
to confirm these hypotheses.
